• Measuring Health-Related Quality of Life by Experiences- The Experience Sampling Method

    Nov 1, 2013, 00:00

  • Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality- A European Overview

    Nov 1, 2013, 00:00

  • Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistan A Decision and Cost Analysis

    Nov 1, 2013, 00:00

  • The Pharmacoeconomic of Cardiology in Russia

    Nov 1, 2013, 00:00

  • Differential Diagnosis of Leg Ulcers – Medical and Health Economics Aspects

    Nov 1, 2013, 00:00

  • Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)

    Nov 1, 2013, 00:00

  • Estimating the Social Distribution of Health in England

    Nov 1, 2013, 00:00

  • Estimating the Budget Impact in Brazilian Public Health Care System of Tocilizumab Reimbursement As a Rheumatoid Arthritis First-Line Biological Therapy

    Nov 1, 2013, 00:00

  • Simulating Patient Populations – Difficulties in Controlling the Roll of the Dice

    Nov 1, 2013, 00:00

  • Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis

    Nov 1, 2013, 00:00

  • A 10-Year Review of the Canadian Common Drug Review- Pharmaceutical Manufacturers’ Success Rate

    Nov 1, 2013, 00:00

  • Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in Finland

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

    Nov 1, 2013, 00:00

  • Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in Colombia

    Nov 1, 2013, 00:00

  • Chronic Patients’ Willingness to Pay for an Alternative Drug with Innovative Characteristics

    Nov 1, 2013, 00:00

  • Emerging Cardiovascular Events Associated with Targeted Anticancer Drugs. Preliminary Results of a Care Line’s Program Based on Audit Vigilance in a Private Health Care in Brazil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

    Nov 1, 2013, 00:00

  • Exploring the Burden of Illness of Hereditary Angioedema in the United Kingdom

    Nov 1, 2013, 00:00

  • Alternative High Level Disinfectants to Processing Flexible Endoscopes

    Nov 1, 2013, 00:00

  • Comparative Evaluation of the Appropriateness of the Prescribing in Geriatrics Inpatients Using Beers Criteria 2012 and 2003

    Nov 1, 2013, 00:00

  • Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases- Health Professionals’ View in Serbia

    Nov 1, 2013, 00:00

  • Analysis of the IQWIG Comments on the Evidence Searches of Dossiers in the German Amnog Process

    Nov 1, 2013, 00:00

  • A Micro-Costing of the Inpatient Management of Febrile Neutropenia in the Irish Health Care Setting

    Nov 1, 2013, 00:00

  • Baseline Characteristics and Vitreoretinal Interface Features in Patients with Vitreomacular Traction and Macular Hole from the MIVI-TRUST Clinical Program

    Nov 1, 2013, 00:00

  • Health Technology Assessment of High-Value Therapies

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ipilimumab for the Treatment of Advanced Melanoma in the Veneto Region, Italy

    Nov 1, 2013, 00:00

  • Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United States

    Nov 1, 2013, 00:00

  • The Qualitative Profile of the Coverage Complaints Made By Health Plan Users to the Federal Regulatory Agency for Private Health Insurance and Plans (ANS)

    Nov 1, 2013, 00:00

  • Trends in the Cost-Effectiveness of Stroke Care

    Nov 1, 2013, 00:00

  • Etanercept 25 Mg Once Weekly Could Be a Cost-Effective Option for Rheumatology Patients in Sustained Clinical Remission

    Nov 1, 2013, 00:00

  • Prometex - Promevoz, Tool Support of Pharmaceutical Care for the Scope of Proper Adhesion in Colombia, 2009-2012

    Nov 1, 2013, 00:00

  • Additional Investments, Added Value, Real World Evidence and Additional Clinical Benefit in the Context of Subgroups of Special Interest

    Nov 1, 2013, 00:00

  • Using Multi-Criteria Decision Analysis to Support Allocation Decisions in Large Translational Research Projects

    Nov 1, 2013, 00:00

  • Re-Establishing the Societal Value of Pediatric Combination Vaccines

    Nov 1, 2013, 00:00

  • An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Economic Evaluation of Pharmacological Treatments for Overactive Bladder

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De La Perfusión Aislada De Extremidad Con Tasonermia En Pacientes Con Sarcoma De Tejido Blando Irresecable

    Nov 1, 2013, 00:00

  • Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes

    Nov 1, 2013, 00:00

  • Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

    Nov 1, 2013, 00:00

  • Applied Comparison of Meta-Analysis Techniques

    Nov 1, 2013, 00:00

  • Evaluación Costo-Efectividad Y De Valor Social De Un Programa De Intervención En Población Infantil En Situación De Vulnerabilidad, Rezago O Déficit En El Desarrollo Integral - Chile 2012

    Nov 1, 2013, 00:00

  • Cost Analysis of Alprostadil (Prostavasin®) as Treatment for Patients with Peripheral Arterial Disease Stages III and IV Compared with Lumbar Sympathectomy in Mexico

    Nov 1, 2013, 00:00

  • The Funding of Orphan Medicines in Europe- Payers Achilles’ Heel?

    Nov 1, 2013, 00:00

  • An Economic Evaluation of the Triple HCV Treatment Regimen for G1 Naïve Patients in the Greek Health Care System

    Nov 1, 2013, 00:00

  • Novel Market Access Models for Cancer Drugs

    Nov 1, 2013, 00:00

  • Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain” Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative Methods

    Nov 1, 2013, 00:00

  • How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

    Nov 1, 2013, 00:00

  • Evaluation of Variable Relevance and Accessibility to Support Personalized Medicine in Breast Cancer

    Nov 1, 2013, 00:00

  • The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy

    Nov 1, 2013, 00:00

  • Pricing and Reimbursment of Pharmaceuticals in Iran

    Nov 1, 2013, 00:00

  • Exploring the Identification of Multiple Sclerosis Incident Cohorts in Claims Databases- Methodology and Challenges

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

    Nov 1, 2013, 00:00

  • Socio-Economic Impact of Alzheimer’s Disease in Gree Pilot Study

    Nov 1, 2013, 00:00

  • Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China

    Nov 1, 2013, 00:00

  • Medico-Economic Evaluation in Fran Methodology and Impact on the Pricing and Reimbursement System

    Nov 1, 2013, 00:00

  • Consumption of Biosimilar Drugs in Campania Region in the Years 2009-2012

    Nov 1, 2013, 00:00

  • Validation of Accept, a New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-life

    Nov 1, 2013, 00:00

  • Evaluation of Associations Among Biomarkers, Correlates and Treatment Efficacy in Clinical Studies in Patients Diagnosed with Non-Psychotic Major Depressive Disorder- A Literature Review

    Nov 1, 2013, 00:00

  • Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio

    Nov 1, 2013, 00:00

  • Evaluate the Status of Pharmacoeconomic Research Development in China from 2002 to 2013

    Nov 1, 2013, 00:00

  • Current and Future Strategy for Osteoporosis Screening and Diagnostics- Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on Demand

    Nov 1, 2013, 00:00

  • Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids- A Systematic Review and Indirect Treatment Comparison

    Nov 1, 2013, 00:00

  • Are Public Subsidies Effective to Reduce Hospitalizations

    Nov 1, 2013, 00:00

  • Direct and Indirect Costs of MS in Ireland

    Nov 1, 2013, 00:00

  • Drug Distribution Strategies Cost in Brazil

    Nov 1, 2013, 00:00

  • User and Treatment Characteristics of Oral Contraceptives in the European Union

    Nov 1, 2013, 00:00

  • Evaluación De Costo-Efectividad De Certolizumab Pegol Comparado Con Etanercept En El Tratamiento De Artritis Reumatoidea En Colombia

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) During Treatment of Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Co-administration of Antipsychotics and Anti-dementia Drugs in Austria

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Don’t Make Me Wait- The Variance Reduction Technique for Faster Monte Carlo Simulations in Cost Effectiveness Models on Web

    Nov 1, 2013, 00:00

  • Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections- A Budget Impact Analysis in the Greek Hospital Setting

    Nov 1, 2013, 00:00

  • Informing the Affordability of Vaccines with Different Health Care Financing Mechanisms

    Nov 1, 2013, 00:00

  • Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing- Impact of Generic Prescribing on Cost

    Nov 1, 2013, 00:00

  • Chronic Patients’ Perceptions About Generic Medicines in Gree Findings from a Cross Sectional Survey

    Nov 1, 2013, 00:00

  • Long-Term Outcomes of Sofosbuvir (SOF) for the Treatment of Chronic Hepatitis C Infected (CHC) Patients

    Nov 1, 2013, 00:00

  • Evidence-Based Methods in Food Sciences and Nutrition

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

    Nov 1, 2013, 00:00

  • Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization Perspective

    Nov 1, 2013, 00:00

  • A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

    Nov 1, 2013, 00:00

  • Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in the United States

    Nov 1, 2013, 00:00

  • Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization- National Estimates for Medicare Beneficiaries, 2002 to 2009

    Nov 1, 2013, 00:00

  • Effectiveness of Montelukast on Asthma Control in Infants- Methodology of a Claims Data Study

    Nov 1, 2013, 00:00

  • Cost-minimization Analysis of Dienogest Versus Gonadotrophin-releasing Hormone Analogues or Dydrogesterone for Endometriosis Treatment in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Linezolid and Vancomycin in Patients with Complicated Skin and Soft-Tissue Infections Caused by Methicilin-Resistant Staphylococcus in Portugal

    Nov 1, 2013, 00:00

  • The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis - Khoala Study

    Nov 1, 2013, 00:00

  • Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec

    Nov 1, 2013, 00:00

  • Análisis Del Impacto En La Demanda De Tecnologías Incluidas En El Plan De Beneficios Colombiano (POS) Posterior A Su Actualización En 2012

    Nov 1, 2013, 00:00

  • Analysis of Spanish Generic Medicines Market- Recommendations to Enhance Long-Term Sustainability

    Nov 1, 2013, 00:00

  • Costo Efectividad Del Antibiótico Oral Vs. Local En Mujeres No Gestantes Con Flujo Vaginal Sugestivo De Vaginosis Bacteriana En Colombia

    Nov 1, 2013, 00:00

  • Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

    Nov 1, 2013, 00:00

  • Applicability of Japanese Health Care Database to Clinical Trial Planning for Dyslipidaemia Drug

    Nov 1, 2013, 00:00

  • Evaluating the Economic Impact of Technological Advances in Diagnostics- The Case of High Throughput Sequencing for Hereditary Breast Cancer

    Nov 1, 2013, 00:00

  • Análise Custo-Minimização (ACM) Do Cloridrato De Valganciclovir Comparado Com Ganciclovir Na Profilaxia Da Infecção Por CMV Em Transplantados Renais

    Nov 1, 2013, 00:00

  • Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching Hospital

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Diagnostic Tests in the Work-Up of Patients with Intermediate Risk of Developing Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Economic Burden of Inpatient Post-Admission Dehydration – Retrospective Database Analysis in Us

    Nov 1, 2013, 00:00

  • Cost Savings in the Hungarian Care Managing Programme

    Nov 1, 2013, 00:00

  • Disposición a Pagar Y Análisis De Conjoint Para Determinar Las Preferencias Por Los Productos Medley En México

    Nov 1, 2013, 00:00

  • Bayesian Analysis of Malformation Outcome in Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy- An Indirect Comparison of Citalopram, Fluoxetine, Paroxetine, and Sertraline

    Nov 1, 2013, 00:00

  • Beyond Patent Expiry- Development of a Model for Pricing Generic Drugs in South Africa

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Diagnostico Etiológico Con Pruebas Rapidas Vs. Sindromico En Mujeres No Gestantes Con Sintomas De Infección Cervical En Colombia

    Nov 1, 2013, 00:00

  • Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Systematic Literature Reviews at the Heart of Health Technology Assessment- A Comparison Across Markets

    Nov 1, 2013, 00:00

  • The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling

    Nov 1, 2013, 00:00

  • Cost Reduction Associated with Use of Subglottic Aspiration to Reduce Ventilator-Associated Pneumonia in Turkey

    Nov 1, 2013, 00:00

  • Dual Back Translation Versus Single Back-Translation Methodology When Translating Patient Reported Outcomes (PRO)

    Nov 1, 2013, 00:00

  • The Use of Dexa Scans in Postmenopausal Osteoporosis Is Associated with Reduced Long Term Fracture Risk

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Ioxaglato Versus Iodixanol En Angiografía Coronaria

    Nov 1, 2013, 00:00

  • Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure- Application in Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Comparative Analysis of the Cost and Metabolic Control in Diabetic Children Using Insulin Pumps

    Nov 1, 2013, 00:00

  • Reduction in Fixation Time and Related Surgical Stress with the Use of Ethicon Securestrap™ Open Absorbable Strap Fixation Device in the Deployment of Intra-Peritoneal Onlay Mesh (IPOM) for Open Ventral Hernia Repair

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por Atonía Uterina En Pacientes Con Factores De Riesgo En Colombia

    Nov 1, 2013, 00:00

  • A Literature Review on the Humanistic and Economic Burden of Mineralocorticoid Excess Syndrome

    Nov 1, 2013, 00:00

  • Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in Japan

    Nov 1, 2013, 00:00

  • Effect of Smoking Status on Health Care Costs and Resource Utilization in Patients with Chronic-Obstructive-Pulmonary-Disease in Clinical Practi A Retrospective Nested Case-Control Economic Study

    Nov 1, 2013, 00:00

  • Comparing Copd Costs By Exacerbation Frequency and Dyspnoea Level in a Primary Care Setting in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost of Inpatient Management of Hypoglycaemia in France

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Abatacept for Treatment of Adults with Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study

    Nov 1, 2013, 00:00

  • Risk Factors Influencing the Viral Transmission and the Potential Development of HPV-Induced Pathologies

    Nov 1, 2013, 00:00

  • Estimation of Generic Utilities in Spanish Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2013, 00:00

  • Model-Based Economic Evaluations in Alzheimer’s Disease - A Review of Modeling Methods

    Nov 1, 2013, 00:00

  • Stroke Prevention in Non-Valvular Atrial Fibrillation- Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Quality Assurance of Fourth Hurdle Concerning to Drugs and Medical Devices

    Nov 1, 2013, 00:00

  • Retrospective Costing Study to Estimate Burden of Heart Failure in Spain

    Nov 1, 2013, 00:00

  • Is It Worth Having Orphan Drug Status in Germany Post-Amnog?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Injectable Atypical Long-Acting Antipsychotics for Chronic Schizophrenia in Poland

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Routine Infant Vaccination Strategies in Russia- An Economic Evaluation

    Nov 1, 2013, 00:00

  • Mothers’ Own Milk for the Feeding of Preterm Infants- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Impacto Económico Y En Discapacidad Del Incrementro De Utilización De Trombolisis En El Cuidado Agudo De L Ictus Isquémico En Chile

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access

    Nov 1, 2013, 00:00

  • An Analysis of the Cost Effectiveness of Left Atrial Appendage Closure for the Prevention of Stroke in Patients with Atrial Fibrillation and Absolute Contraindications to Warfarin Therapy

    Nov 1, 2013, 00:00

  • Health Insurance Cost of Epilepsy in Hungary- A Cost of Illness Study

    Nov 1, 2013, 00:00

  • Evolución En El Uruguay De Tazas De Utilización De Cateterismo Cardíaco Diagnostico Par a Cardiopatía Congénita En Menores De 18 Años (1995-2012)

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Step-Down Strategy Versus Conventional Therapy in the Treatment of Nosocomial Pneumonia Caused by Gram Positive Bacteria in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Statins for Primary Prevention in Newly Diagnosed Type 2 Diabetes Patients in the Netherlands

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Oncology Drugs

    Nov 1, 2013, 00:00

  • Qualidade De Vida Em Pacientestransplantados Renais

    Nov 1, 2013, 00:00

  • Relative Clinical and Economic Value of Ipilimumab in Mexico

    Nov 1, 2013, 00:00

  • Baseline Characteristics, Weight and Glycaemic Change Among Patients in the United Kingdom with Type 2 Diabetes Mellitus (T2DM) Prescribed a New Antidiabetic Treatment Class in a Real World Setting

    Nov 1, 2013, 00:00

  • Incretin Therapy for Patients with Type 2 Diabetes in Spain- A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin

    Nov 1, 2013, 00:00

  • Predicting the Frequency of Severe and Non-Severe Hypoglycaemia in Insulin Treated Type-2 Diabetes Subjects

    Nov 1, 2013, 00:00

  • The Adoption of Health Technologies- A Survey of Brazilian Policy Makers

    Nov 1, 2013, 00:00

  • Comparative Efficiency Research- Meta-Analysis of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Análisis De La Carga Financiera De Las Principales Enfermedades Reumatológicas

    Nov 1, 2013, 00:00

  • Resource Use and Cost of Diagnosis and Management of Breast Cancer by Stage in an Irish Teaching Hospital

    Nov 1, 2013, 00:00

  • Statin Cost-Effectiveness in Patients with Previous Coronary Heart Disease- A Systematic Review of the Cost-Effectiveness Analysis Derived from Single Randomised Clinical Trials

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Pruebas Para La Tamización De Bacteriuria Asintomática Durante La Gestación

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

    Nov 1, 2013, 00:00

  • Burden of Disease of Cervical Dystonia in the United Kingdom

    Nov 1, 2013, 00:00

  • Economic Impact of Stroke Episode in Patients Previous Diagnosed with Atrial Fibrillation in Private Health System in Brazil

    Nov 1, 2013, 00:00

  • Economic Evaluation of Universal Antenatal HIV Screening Compared with Current “At Risk” Policy in Israel

    Nov 1, 2013, 00:00

  • Aflibercept in Neovascular (Wet) Age-Related Macular Degeneration- An Analysis of the Payer Decision Landscape

    Nov 1, 2013, 00:00

  • Association Between Non-Motor Symptoms and Health Care Utilization Among Patients with Parkinson’s Disease in the United States

    Nov 1, 2013, 00:00

  • Doubling of Health Care Costs Among Asthma Patients with COPD Diagnosis and Its Associated Co-Morbidities in a Claims Database in the United States

    Nov 1, 2013, 00:00

  • Driving After Drinking- Hospitalization, Mortality Rate, and Costs Pre and Post Prohibition in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands- Retrospective Analysis of Health Insurance Data

    Nov 1, 2013, 00:00

  • Modelling the Relationship Between the WOMAC Osteoarthritis Index and EQ-5D

    Nov 1, 2013, 00:00

  • Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis- Results of a European Chart Review Study

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Health-Related Quality of Life Using EQ-5D

    Nov 1, 2013, 00:00

  • Are Israeli Adults Willing to Pay Higher Health Taxes for a Wider Coverage of Life-Extending Medications?

    Nov 1, 2013, 00:00

  • Needs Assessment of Patients Treated in Community Psychosocial Centers in São Paulo, Brazil

    Nov 1, 2013, 00:00

  • Characteristics of Hospitalizations Due to an Episode of Relapse in Multiple Sclerosis Brazilian Patients- A Retrospective Administrative Claims Analysis Under the Public Payer Perspective

    Nov 1, 2013, 00:00

  • Nutrieconomic Exploratory Assessment of a Daily Consumption of Plant Sterols-Enriched Dairy Products on Statin’s Initiation Delay- A Consumer Perspective Approach

    Nov 1, 2013, 00:00

  • Budget Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • The Burden of Pneumonia in Malaysia, Indonesia and Philippines

    Nov 1, 2013, 00:00

  • Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)

    Nov 1, 2013, 00:00

  • Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies

    Nov 1, 2013, 00:00

  • Comparison of the Prices Used in the Manufacturers’ Budget Impact Analyses and the Prices from Reimbursed Drugs List

    Nov 1, 2013, 00:00

  • Hospital Resource Use in Chronic Disease Combinations- Is It Enough to Just Add Them Up?

    Nov 1, 2013, 00:00

  • Podcasts as a Learning Tool in a Research Methods Course for Pharmacy Students

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Various Combinations of Human Papillomavirus (HPV)-Based Primary Screening Testing, Including Genotyping for HPV 16/18, for Cervical Cancer Screening in Mexico

    Nov 1, 2013, 00:00

  • Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary

    Nov 1, 2013, 00:00

  • Cost of Microvascular and Macrovascular Complications in Peoples with Diabetes Type 1 and Type 2 in Bulgaria

    Nov 1, 2013, 00:00

  • Can Administrative Data Predict Chemotherapy Adverse Events?

    Nov 1, 2013, 00:00

  • A Bayesian Dynamic Model of Asthma in the Real Life

    Nov 1, 2013, 00:00

  • It Application for Post Marketing Drug Registries

    Nov 1, 2013, 00:00

  • Juggling Jurisdictions- Methods for Conducting Modular Systematic Reviews?

    Nov 1, 2013, 00:00

  • Feasibility of a Survey on the Willingness-To-Pay for Colorectal Cancer Screening Using Social Networks

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Medication Adherence Enhancing Interventions- A Systematic Review

    Nov 1, 2013, 00:00

  • Economic Activity of Cancer Survivors in Poland

    Nov 1, 2013, 00:00

  • Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012)

    Nov 1, 2013, 00:00

  • Adding a Reminder Short Message Service (SMS) Before and Tablet Computer During Clinic Improves Electronic Patient Reported Outcome Measures (ePROMS) Collection

    Nov 1, 2013, 00:00

  • Estimating the Association Between the Oxford Hip Score (OHS) and EQ-5D Utility Values Using Direct and Response Mapping Methods

    Nov 1, 2013, 00:00

  • Approaches for Estimating Burden of Pneumococcal and Rotavirus Diseases- Conceptual Framework and Systematic Review

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in Germany

    Nov 1, 2013, 00:00

  • Treatment Patterns of Atrial Fibrillation (AF) in Latin America

    Nov 1, 2013, 00:00

  • The Short-Term Impact of Particulate Matter Exposure on the Risk of Prescription of Cardiorespiratory Drugs in Italy

    Nov 1, 2013, 00:00

  • The Importance of Safety Aspects in the Amnog Process in Germany- Is the G-Ba Assessment Consistent with That of the CHMP?

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus Erythematosus

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Spain- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Utilization Patterns for Treatment with Strong Opioids for Chronic Back Pain in Germany

    Nov 1, 2013, 00:00

  • Compliance with Preventive Recommendations in Primary Care and Rate of Potentially Avoided Hospitalizations by Diabetes, Chronic Heart Failure or Chronic Pulmonary Obstructive Disease

    Nov 1, 2013, 00:00

  • Impact of Medication Adherence on Health Care Cost in COPD

    Nov 1, 2013, 00:00

  • The Sustainability of Irish Pharmaceutical Expenditure

    Nov 1, 2013, 00:00

  • Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors- The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

    Nov 1, 2013, 00:00

  • Evaluation of the Length of Hospital Stay for Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Investigating the Value of Abatacept IV in the Treatment of Rheumatoid Arthritis- A Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol- 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South India

    Nov 1, 2013, 00:00

  • The Relationship Between Scientific Research, Clinical Trials and FDA Drug Approval

    Nov 1, 2013, 00:00

  • Análisis De Minimización De Costos Del Uso Del Aflibercept En Degeneracion Macular Relacionada Con La Edad En Colombia

    Nov 1, 2013, 00:00

  • ¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios Científicos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?

    Nov 1, 2013, 00:00

  • External Validation of the Syreon Diabetes Model

    Nov 1, 2013, 00:00

  • Clinical and Cost-Effectiveness of Non-Pegylated Liposomal Doxorubicin for Non-Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2013, 00:00

  • Application of Health Technology Assessment and Pharmacoeconomics in the Decision-Making Process in Selected Eu Member States

    Nov 1, 2013, 00:00

  • Monitoring Health Processes in the Real World- An Italian Population Database Experience

    Nov 1, 2013, 00:00

  • Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Acute Asthma Characteristics and Asthma Control in Latin America

    Nov 1, 2013, 00:00

  • Weight Loss of ≥3% in Type II Diabetes Patients Is Associated with Weight Change Property of Newly Prescribed Anti-Diabetic Medicine in Anti-Depressant Users Over a 12-Month Follow-Up Period

    Nov 1, 2013, 00:00

  • The Impact of Increasing Pain Severity on Impairment of Regular Daily Activities

    Nov 1, 2013, 00:00

  • Patients Preferences for Long-Term Treatment After Acute Coronary Syndrome- A Discrete-Choice Experiment and Analytic Hierarchy Process

    Nov 1, 2013, 00:00

  • Overview of Coverage with Evidence Development in Sweden

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the SF-6D Questionnaire for Use in Arabic-Speaking Countries

    Nov 1, 2013, 00:00

  • Prevelance of Hydeted Disease in Sugicaly Operated Patient in Some Libyan General Hospital

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine in Chronic Heart Failure in Greece

    Nov 1, 2013, 00:00

  • Assessing Product Safety via Patient Based Active Surveillance (AS)- A Study in 30.000 Women Using Hormone Replacement Therapy (HRT)

    Nov 1, 2013, 00:00

  • Economic Evaluation of Sitagliptin in Diabetes Mellitus Treatment in China

    Nov 1, 2013, 00:00

  • ¿Los Formularios Nacionales (Cuadros Básicos) Provocan Oligopolios E Incentivan a Tener Precios Altos?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paricalcitol in End Stage Chronic Kidney Disease Secondary Hyperparathyroidism Patients on Dialysis, in Brazil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France

    Nov 1, 2013, 00:00

  • Health Care Costs of HIV in the Czech Republic. A Single Center Analysis

    Nov 1, 2013, 00:00

  • How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Current Standard of Care in the Management of Type 1 and Type 2 Diabetes Mellitus in the Spanish Health System

    Nov 1, 2013, 00:00

  • Multi-state Statistical Modelling to Quantify an Individual-based Micro Simulation Model for Radiotherapy Treatment in Lung Cancer Patients

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in the Children and Adolescents

    Nov 1, 2013, 00:00

  • Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients- Significant Increase of Transportation Needs and Home Visits

    Nov 1, 2013, 00:00

  • Treatment and Outcome Analysis of Rodenticide Poisoning in Tertiary Care Hospital in South India

    Nov 1, 2013, 00:00

  • Crossover Adjustment in Oncology Trials Using a Rank Preserving Structural Failure Time Model (RPSFTM)- Wrapping Bootstraps Around Estimates of Life Expectancy for CE Models

    Nov 1, 2013, 00:00

  • Disentangling Effects on Fatal and Non-Fatal Cardiovascular Events Over Time

    Nov 1, 2013, 00:00

  • The Impact of Public Formularies Guidelines on Community Acquired Pneumonia (CAP) Drugs in Mexico

    Nov 1, 2013, 00:00

  • A Unified Methodological Framework for the Economic Evaluation of Therapeutic Medical Devices

    Nov 1, 2013, 00:00

  • Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH)- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • A Systematic Review of the Effectiveness of Taxes in Preventing Obesity Trends

    Nov 1, 2013, 00:00

  • Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Skin and Soft Tissue Infection in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con Cineangiocoronariografías Realizadas En Uruguay Financiadas Por El Fondo Nacional De Recursos

    Nov 1, 2013, 00:00

  • Assessing Non-Inferiority of Aclidinium Bromide 400 mG Bid Versus Tiotropium 18 mG and 5 mG Qd in Patients with Chronic Obstructive Pulmonary Disease (COPD) by Means of a Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto Económico

    Nov 1, 2013, 00:00

  • Preliminary Testing of the Sagit Tool- A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Dos Formulaciones De Toxina Botulínica Tipo a (TBA) En Colombia Para El Tratamiento De La Parálisis Cerebral Infantil (PCI)

    Nov 1, 2013, 00:00

  • Estimating the Cardiovascular Benefits of DPP-4 Inhibitors- A Simulated Study

    Nov 1, 2013, 00:00

  • A Flexible Multi-State Modelling Framework for the Simulation of Cancer Progression and Cancer Care

    Nov 1, 2013, 00:00

  • Estimating Market Potential for Biosimilar Introduction

    Nov 1, 2013, 00:00

  • Cost Effectiveness Evaluation of a Rotavirus Vaccination Program in Argentina

    Nov 1, 2013, 00:00

  • Assessment of Cost-Effectiveness Models for Biologics in the Management of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient Populations

    Nov 1, 2013, 00:00

  • Pricing and Reimbursement System of Orphan Drugs in the Czech Republic

    Nov 1, 2013, 00:00

  • Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast Cancer

    Nov 1, 2013, 00:00

  • Budget Impact Analysis for the Use of Vandetanib in Mexican Adult Patient Diagnosed with Advanced Unresectable Medullary Thyroid Cancer

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine for Chronic Heart Failure NYHA II to IV Class with Systolic Dysfunction in Ireland

    Nov 1, 2013, 00:00

  • An Analysis of the Cost of Switching Renal Transplant Patients from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus Based on Differences in Trough Concentration Variability in the United Kingdom

    Nov 1, 2013, 00:00

  • Medical Costs of Patients with Rheumatoid Arthritis and Association with Global Disease Activity in Turkey

    Nov 1, 2013, 00:00

  • Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia

    Nov 1, 2013, 00:00

  • Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQ”

    Nov 1, 2013, 00:00

  • Measuring Pros That Matter to Bariatric and Body Contouring Surgery- The Body-Q

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Economic Burden of Axial Spondyloarthritis Related to Paid Work and Household Productivity at Baseline in the Rapid-axSpA Study- Differences and Similarities Between Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the Polish Version of “Disabilities of the Arm, Shoulder and Hand” (DASH) and Quickdash Questionnaires

    Nov 1, 2013, 00:00

  • Quality of Life Improvement with Etanercept in Patients with Moderate/Severe Psoriasis from Central and Eastern Europe, Latin America and Asia

    Nov 1, 2013, 00:00

  • Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Health Economic Modelling of Sequential Therapies for Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2013, 00:00

  • Proposal of Economic Evaluation Guideline in Japan

    Nov 1, 2013, 00:00

  • Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)

    Nov 1, 2013, 00:00

  • Public Health Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • Can the Use of Social Media and Mobile Apps Improve Patient Knowledge of Disease and Health Outcomes? A Systematic Review

    Nov 1, 2013, 00:00

  • Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2013, 00:00

  • Eighty-Nine Local Roche Sponsored French Studies Performed in the Past 10 Years Were Evaluated to Determine How Patient Reported Outcomes Were Used

    Nov 1, 2013, 00:00

  • Frequency of Lower Urinary Tract Symptoms in Men and Women in Hungary – Results of an Open Label Questionnaire Study from 2012

    Nov 1, 2013, 00:00

  • Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and Spain

    Nov 1, 2013, 00:00

  • Estimation of the Cost-Effectiveness of Apixaban in Non-Valvular Atrial Fibrillation in Argentina

    Nov 1, 2013, 00:00

  • HTA National Public Policy and Their Socio-Economic Environment- A European Perspective

    Nov 1, 2013, 00:00

  • Quality of Care for Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • Transparency of the Medicines Reimbursement System in Ireland- A Quantative Analysis of the Influences on Reimbursement Decisions [2006-2013]

    Nov 1, 2013, 00:00

  • A Comparative Study of the Role of Disease Severity in Drug Reimbursement Decision Making in Belgium, France, the Netherlands and Sweden

    Nov 1, 2013, 00:00

  • Application of Logistic Regression for Signal Detection and Risk Assessment of Macrolide-Associated Torsade De Pointes

    Nov 1, 2013, 00:00

  • Barriers Underlying Limited Utilisation of Vaccines Throughout Life (Lifespan Immunisation)

    Nov 1, 2013, 00:00

  • The Transparency of National Health Care Costs in the ‘European Union Five (EU-5)’

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic in Europe Union and the United States

    Nov 1, 2013, 00:00

  • Custos De Pneumonias Hospitalizadas No Brasil- Análise Comparativa Por Diferentes Métodos De Custeio

    Nov 1, 2013, 00:00

  • Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study

    Nov 1, 2013, 00:00

  • Analysis Cost Effectiveness of Pharmacological Prophylaxis of Contrast-Induced Nephropathy

    Nov 1, 2013, 00:00

  • Health Related Quality of Life by Line of Therapy in Imatinib-Resistant or Imatinib-Intolerant Patients with Chronic Myeloid Leukemia Treated with Bosutinib Measured by EQ-5D

    Nov 1, 2013, 00:00

  • The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium

    Nov 1, 2013, 00:00

  • The E-Health Impact Questionnaire- Developing a Tool to Measure the Effects of Using Health-Related Websites

    Nov 1, 2013, 00:00

  • Patients as a Source for Cost of Rheumatoid Arthritis Study

    Nov 1, 2013, 00:00

  • Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Considering Economic Analyses in the Revision of the Preventive Vaccination Law- A New Direction for Health Policy-Making in Japan?

    Nov 1, 2013, 00:00

  • Real Life Effects of Liraglutide Supports Those Shown in RCTs

    Nov 1, 2013, 00:00

  • How Well Do We Understand the Economic Burden Associated with Dementia? A Focus on Trends in Care Home Costs and Future Perspectives in the United Kingdom

    Nov 1, 2013, 00:00

  • Hypercholesterolemia’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium

    Nov 1, 2013, 00:00

  • Costos Asociados a Eventos Cardiovasculares En Pacientes Con Artritis Reumatoide Afiliados Al Régimen Subsidiado En Colombia

    Nov 1, 2013, 00:00

  • Costs and Consequences of Oral Anticoagulation in Atrial Fibrillation in Colombia

    Nov 1, 2013, 00:00

  • Collaborative Care for Depression Management in Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Nice STA Decisions- An Analysis of How Advice Differs Between Preliminary and Final Guidance

    Nov 1, 2013, 00:00

  • A Systems-Thinking Approach for the Health Care Industry- Strategies and Insights for Biopharma, Payers and Providers

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Para El Manejo Farmacológico De La Hemofilia a Severa En 5 Entidades De Aseguramiento En Colombia

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Everolimus in the Treatment of Metastatic Renal Cell Cancer in the Netherlands

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia

    Nov 1, 2013, 00:00

  • Economic Burden of Patients with Painful Diabetic Neuropathy in Europe- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Methodological Approaches for Modeling Cardiovascular Events in Cost-Effectiveness Analyses Based on Outcome Trials

    Nov 1, 2013, 00:00

  • Efecto De La Determinación De La Concentración Capilar De Proteína C Reactiva En La Tasa De Prescripción De Antibióticos Para El Tratamiento De Infección De Vías Respiratorias Altas (Análisis De Costo-Efectividad)

    Nov 1, 2013, 00:00

  • Comparative Responsiveness of Direct and Mapped SF-6D Preference-Based Measures in Colorectal Cancer

    Nov 1, 2013, 00:00

  • Developing Personalized Medicine Drugs - Incentives for Pharmaceutical Companies

    Nov 1, 2013, 00:00

  • A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and Comparisons

    Nov 1, 2013, 00:00

  • Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care Setting

    Nov 1, 2013, 00:00

  • La Utilidad Predictiva Del Euroscore Puede Ser Mejorada Al Adicionar Valores De Peptido Natriurético Tipo B O De Hemoglobina

    Nov 1, 2013, 00:00

  • The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment

    Nov 1, 2013, 00:00

  • Differences in Health Care Resource Utilization and Expenditures Among Schizophrenic Patients in the United States by Health Insurance Status, 2007-2008

    Nov 1, 2013, 00:00

  • Disease Status, Treatments and Outcomes of Patients with Ankylosing Spondylitis Receiving Their First Biologic in the United States and European Union

    Nov 1, 2013, 00:00

  • Derivation of Severity Index for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Cost-Outcome Description of Clinical Pharmacist Interventions in a University Teaching Hospital

    Nov 1, 2013, 00:00

  • Attitude of Parents Towards Obligatory and Recommended Childhood Vaccination

    Nov 1, 2013, 00:00

  • Economic Consequences of Nonalcoholic Steatohepatitis in the United States

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sugammadex for Routine Reversal of Neuromuscular Blockade, with Extubation at a TOF Ratio of 0.9, in Anaesthetised Patients Undergoing Elective Surgery in England and Wales

    Nov 1, 2013, 00:00

  • Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes Asssesment of Thai Chronic Stable Angina Pectoris(CSAP)

    Nov 1, 2013, 00:00

  • Regulating the Access to an Adequate and an Integral Assistance in Brazilian Private Health Plans

    Nov 1, 2013, 00:00

  • COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

    Nov 1, 2013, 00:00

  • Health Care Cost of Type 2 Diabetes Patients in Gree Sub-Population Analysis

    Nov 1, 2013, 00:00

  • Health Technology Assessment- Is It the Right Piece for the Jordanian Health Care Puzzle?

    Nov 1, 2013, 00:00

  • Testing the Eunethta Internal Validity of Randomized Controlled Trials Guideline and Tool in Hungary

    Nov 1, 2013, 00:00

  • Impacto Do Uso Do Microdebridador Nos Desfechos E Custos Nas Cirurgias Endoscópicas Nasais

    Nov 1, 2013, 00:00

  • Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

    Nov 1, 2013, 00:00

  • Evaluating Fatigue in Fibromyalgia- Development and Validation of the Daily Diary of Fatigue Symptoms in Fibromyalgia (DFS-Fibro)

    Nov 1, 2013, 00:00

  • Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in Mexico

    Nov 1, 2013, 00:00

  • Impact of Comorbidity Burden on Real-World Health Care Costs of Rheumatoid Arthritis Patients in Turkey

    Nov 1, 2013, 00:00

  • Comparing Quality of Life and Clinical Variables for the Prediction of Future Medical Events

    Nov 1, 2013, 00:00

  • Using an Excel Calculator to Estimate Ankylosing Spondylitis Costs in Turkey

    Nov 1, 2013, 00:00

  • Does Europe Reward Reformulations? A Data Driven Analysis of Value Preservation Through Reformulation

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin

    Nov 1, 2013, 00:00

  • Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

    Nov 1, 2013, 00:00

  • Further Validation of a New Questionnaire to Measure Satisfaction with Medical Care in Patients with Atrial Fibrillation (SAFUCA) in Spain

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

    Nov 1, 2013, 00:00

  • Modeling the Impact of Disease Modifying Treatment on Time to Disability Health States in Multiple Sclerosis- An Evaluation of Oral Therapies Through Indirect Comparisons of 6-Month Confirmed Disability Progression

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário- Quanto Custaria Ao Sistema Público De Saúde Brasileiro Incrementar, Por Meio De Transplantes, O Tratamento Da Doença Renal Crônica Terminal?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Capsule Endoscopy in Screening for Colorectal Cancer in Japan

    Nov 1, 2013, 00:00

  • Costs of COPD in Fran A National Database Analysis

    Nov 1, 2013, 00:00

  • Cost Analysis of a Fibrin Sealant Patch for Mild, Moderate and Problematic Soft Tissue Surgical Bleeding- A Hospital Perspective

    Nov 1, 2013, 00:00

  • Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Clinical Outcome Assessments in FDA Oncology Labels Since 2010

    Nov 1, 2013, 00:00

  • Evaluating the Cost Effectiveness of Gene Expression Profiling and Immunohistochemistry Tests

    Nov 1, 2013, 00:00

  • Variability of Clinical Practice for Bariatric Surgery in Spain

    Nov 1, 2013, 00:00

  • Health Care Resources Utilization in Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Mobile Phone Use in Patient Reported Outcomes – A Literature Search

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom

    Nov 1, 2013, 00:00

  • Cost Analysis of an Intensive Care Unit

    Nov 1, 2013, 00:00

  • Economic Impact of Including Sequential Bevacizumab for the Treatment of Patients with Kirsten Ras Wild Type Unresectable Metastatic Colorectal Cancer in Four Latin American Countries

    Nov 1, 2013, 00:00

  • Scandinavian Drug Reimbursement and Coverage Decisions- The Role of HTA

    Nov 1, 2013, 00:00

  • Microsimulation or Cohort Modelling? A Case Study in Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

    Nov 1, 2013, 00:00

  • Graphic Health Warnings on Cigarette Packs in Qatar- Pre-Implementation Awareness and Perception Among the General Public

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Chronic Pain Management in Russian Cancer Patients

    Nov 1, 2013, 00:00

  • Development of an Interviewer-Administered Version of the Asthma Control Questionnaire (ACQ-IA) for 6-10 Year Old Patients in 11 Languages

    Nov 1, 2013, 00:00

  • Survival Analysis Used in Company Submissions to the National Centre for Pharmacoeconomics, Ireland

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United Kingdom

    Nov 1, 2013, 00:00

  • Budget Impact of Paliperidone Palmitate in Austria

    Nov 1, 2013, 00:00

  • Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation- A Community Study

    Nov 1, 2013, 00:00

  • Novel Oral Anticoagulants Versus Warfarin – A Business Case Analysis

    Nov 1, 2013, 00:00

  • Cost Analysis for Patients Hospitalised for Heart Failure in Germany

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Hip and Thigh Injuries in Hungary in 2009

    Nov 1, 2013, 00:00

  • ISPOR 16th Annual European Congress Author Index

    Nov 1, 2013, 00:00

  • Comparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records

    Nov 1, 2013, 00:00

  • An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine-Rituximab in First-Line Indolent NHL- A Patient-Level Simulation

    Nov 1, 2013, 00:00

  • Paediatric Gastroenteritis- Disease Burden, Cost and Loss of Productivity of Malaysian and Vietnamese Parents

    Nov 1, 2013, 00:00

  • Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC)- A Systematic Review and Indirect Comparison of Safety and Efficacy

    Nov 1, 2013, 00:00

  • Different Injection Frequencies of Basal Insulins in Type 2 Diabetes Patients Under Real-Life Conditions- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Development of Novel Imaging Tests to Select Patients for Individualized Therapies- Are They Worth Further Investment?

    Nov 1, 2013, 00:00

  • The Cost of Clostridium Difficile Infection in Hungary

    Nov 1, 2013, 00:00

  • Catching the Low-Hanging Fruit in Medicines Optimisation

    Nov 1, 2013, 00:00

  • Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence Levels

    Nov 1, 2013, 00:00

  • Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom- Results from a General Practice Population Study

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas Conjugadas 10 Y 13 Valente Para Niños En Antioquía, Colombia

    Nov 1, 2013, 00:00

  • Quality of Life Benefits and Cost Impact of Prolonged Release Oxycodone/Naloxone Versus Prolonged Release Oxycodone in Patients with Moderate to Severe Pain and Opioid-Induced Constipation Despite the Use of 2 Laxatives- A UK Cost Utility A ...

    Nov 1, 2013, 00:00

  • Time Savings with Once-Monthly C.E.R.A.- A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy

    Nov 1, 2013, 00:00

  • The List of Medicines for COPD Treatment in State Formulary of Ukraine and Related Costs

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário Do Oclusor Septal Percutâneo Para O Fechamento De Comunicação Interatrial (CIA) Do Tipo Ostium Secundum

    Nov 1, 2013, 00:00

  • Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada- A Questionnaire-Based Study

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

    Nov 1, 2013, 00:00

  • Etanercept Provides Improved Quality of Life Regardless of the Presence of Psoriatric Arthritis in Moderate/Severe Psoriasis Subjects from Central and Eastern Europe, Latin America and Asia

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life of Patients on Opiate Replacement Therapy

    Nov 1, 2013, 00:00

  • A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

    Nov 1, 2013, 00:00

  • Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden- A Follow-Up of 38,956 Patients in a Real Clinical Setting

    Nov 1, 2013, 00:00

  • Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States

    Nov 1, 2013, 00:00

  • Costs Associated with Cold Chain Used to Store and Transport Thermally Unstable Antiretroviral Drugs

    Nov 1, 2013, 00:00

  • Clinical Significance of Change in the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Score in Adult Growth Hormone Deficiency (AGHD)

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Apomorphine in the Treatment of Advanced Parkinson Disease in the UK and Germany- Results from a Multicounty Decision Analytic Model

    Nov 1, 2013, 00:00

  • Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

    Nov 1, 2013, 00:00

  • The Review of Publications of Pharmacoeconomic Research in Russia During 2007-2012

    Nov 1, 2013, 00:00

  • A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin America

    Nov 1, 2013, 00:00

  • Identification and Qualitative Assessment of Real World Data Sources- Example of Lymphoma and Multiple Myeloma in Europe

    Nov 1, 2013, 00:00

  • Health-State Utilities in Measuring Health-Related Quality of Life Among Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119 (current)
  • 120
  • »